Multi-pathogen infections and Alzheimer's disease

Dana Vigasova1,2, Michal Nemergut2, Barbora Liskova2

  • 1International Clinical Research Center, St. Anne's University Hospital Brno, Pekarska 53, 656 91, Brno, Czech Republic.

Microbial Cell Factories
|January 29, 2021
PubMed

Insights

Alzheimer's disease may be triggered by multiple infections, not just one pathogen. Identifying and treating various microbes could lead to new diagnostic and treatment strategies for this neurodegenerative condition.

Area of Science:

  • Neuroscience
  • Infectious Diseases
  • Pathology

Background:

  • Alzheimer's disease (AD) is a neurodegenerative disorder linked to amyloid-beta and tau pathology.
  • Current AD treatments are not disease-modifying, and many clinical trials have failed.
  • The amyloid-beta peptide's antimicrobial function suggests infection may initiate AD.

Purpose of the Study:

  • To review the potential role of multi-pathogen infections in Alzheimer's disease etiology.
  • To explore how co-existing pathogens and biofilms might contribute to AD pathogenesis.
  • To propose novel diagnostic and therapeutic strategies based on a multi-pathogen infection model.

Main Methods:

  • Literature review focusing on infectious agents implicated in Alzheimer's disease.
  • Analysis of the link between microbial infections, neuroinflammation, and neurodegeneration in AD.
  • Synthesis of evidence supporting a multi-pathogen hypothesis for AD.

Main Results:

  • Alzheimer's patients exhibit increased susceptibility to infections due to compromised blood-brain barrier and immune function.
  • Chronic neuroinflammation and neurodegeneration can result from various microbial infections (viral, bacterial, fungal, parasitic).
  • Herpesviruses and periodontal bacteria are frequently associated with AD, but multi-pathogen involvement is likely.

Conclusions:

  • Recognizing the potential for multiple pathogens and biofilms in AD etiology is crucial.
  • Simultaneous diagnostic testing for major pathogens could improve detection rates.
  • Developing multi-antimicrobial treatments (antiviral, antibacterial, antifungal, anti-biofilm) may offer new therapeutic avenues for Alzheimer's disease.

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.1K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
585
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
140
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
11.2K
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.0K